What's happening
Reference profile
Generated 19:57 ET
RLMD — Relmada Therapeutics, Inc. Common Stock is up 11.4%, at 4.54, on $7.9M traded, 1.7× 20-day volume. Score 68. Primary driver: $7.9M traded. Supply intelligence: mixed supply · 54.
Get alerts on $RLMD
Halts, resumptions, new filings, and updated reports — in your inbox within minutes of the event.
Free · one email per event, no digests or spam · unsubscribe anytime · joins real followers
Free float
92.0M
2026-06-09
Shares out
106.7M
latest detail
Market cap
$434.1M
at ref price
Short interest
14.8%
2026-08-31
Float rotation
0.02×
latest snapshot
20d dollar vol
$4.6M
baseline
Gap quality
mixed supply · 54
live supply-pressure model
Supply factor
positive gap demand
detector reason
Supply factor
large float supply
detector reason
Supply factor
elevated short interest
detector reason
This estimates whether a gap is clean, squeeze-prone, mixed, or supply-heavy using float, float rotation, short interest, market cap, split risk, and live volume. Registered resale/ATM exhaustion is a planned deeper parser layer.
2026-09-11 14:55 ETSignalRelmada Therapeutics, Inc. Common Stock is up 11.4%, at 4.54, on $7.9M traded, 1.7× 20-day volume. Score 68. Primary driver: $7.9M traded. Supply intelligence: mixed supply · 54.
2026-08-068-KItem 2.02 — Results of operations and financial condition; Item 7.01 — Regulation FD disclosure +1 more SEC
2026-07-288-KItem 7.01 — Regulation FD disclosure; Item 9.01 — Financial statements and exhibits SEC
2026-05-288-KItem 5.03 — Amendments to charter or bylaws; Item 9.01 — Financial statements and exhibits SEC
2026-05-128-KItem 2.02 — Results of operations and financial condition; Item 7.01 — Regulation FD disclosure +1 more SEC
Latest detector signalscore 68